Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No change to the Stalicla website regards SFX-01
https://stalicla.com/pipeline
STP2
STP2, or SFX-01, is a stabilized synthetic form of sulforaphane for which STALICLA has acquired the rights for neurodevelopment disorders worldwide from Evgen Pharma in October 2022.
STP2 is being advanced as a precision medicine treatment candidate for a subgroup of patients with ASD called Phenotype 2. Phase 1 data is currently being evaluated to support further clinical development into phase 2 trials.
One reality is that Stalicla still have SFX-01 on their website...
Amateurs alway expect good things winners resspect reality.
There’s a huge difference !
Yes the news regarding the dispute is significant. What are people anticipating with the response by Stalicla? You’d like to think news will come soon, it’s surely fairly straightforward, if Stalicla don’t believe conditions have been met they can surely advise what they are. I’m expecting a positive outcome, the board seem confident they have done everything asked of them many months ago.
Obviously positive news from Stalicla would be a bonus..
"The Company anticipates publication of the radio-sensitisation data for SFX-01 in models of rhabdomyosarcoma from collaborator La Sapienza University, Rome in early 2024."
The radio-sensitisation data should be interesting and we might see Huw do the media rounds when this is released.
Can’t seem to get a live price for this share HL stuck on 1.p
Not moved all day .
Need this RNS to be published as only showing up on this board
In vivo results are encouraging looking forward to the published data
Think this is the problem spread 0.20 now !
Let’s hope this afternoon does better
Hold for now
Gla
Spread to big.18%.put investors off
Holders don't want to attract any more trolls so keep quiet...
If I bought any more I'd have to issue a TR1 ;-)
Just need news of the Stalicla payment and progress and this goes off like a rocket
Cancer treatment= take this SFX-01 pill, get some radiotherapy and you should be all clear in a month' that's the best outcome for everyone
Ok thanks 🙏
Good luck I am in lol
News just getting out Tobethebest.....watch when the herd come....now climbing up the leaderboard in the top 10 now
Why so little interest on the board if this is going to fly?
Where are the big guns?
Trades seem small
Now on the leaderboard.....looking very strong and buying pressure very strong
Strong buying pressure from the opening bell
Fabulous news
Good news
Will the confirmation of SFX-01 radiosensitisation effect as reported last year have an effect on SFX-01 in bowel cancer treatment ?
Should add some additional value to the measly MCAP or at least add a tick in the future value box for SFX-01/Evgen
Good news but still a very long way to completion of P3 trials and a legal & commercial product.
Radar, why are a sexist, i am not a lad, son but a woman so get your facts correct.
You may not give advice but you must think you're a great lad to have houses and businesses.
Get a life, son.
Well i do alright pal from my technical analysis and charting. Just come back off a nine week holiday, own my own houses and have businesses , so does me ok.
Radar i don't give investment advice.....i do my own research and technical and charting and buy and sell when i want.
Some may genius ....I say life is a dance between free will and destiny
This must be one of the best pieces of investment advice ever:
....the reason you should buy now is they were 8.00 two years ago and now at rock bottom at 1.00-1.10 and a bargain.....i find stocks that are at the lowest and primed for a bounce up.....i did it with LIB last week bought at 2.25 and went to 8.00 and sold at multi-bag profits. I did it with CSFS and are now five times the price there and still hold, so its about timing and choosing wisely and i think now is a great time to be in here
WOW what a genius.
Welcome aboard CJ39 hoping you get your iphone15 very soon
Mannnan most people buy shares to make money and buy when cheap and gives them a great opportunity to make profit and gains.....the reason you should buy now is they were 8.00 two years ago and now at rock bottom at 1.00-1.10 and a bargain.....i find stocks that are at the lowest and primed for a bounce up.....i did it with LIB last week bought at 2.25 and went to 8.00 and sold at multi-bag profits. I did it with CSFS and are now five times the price there and still hold, so its about timing and choosing wisely and i think now is a great time to be in here
Good luck CJ39, it would be nice for a shareholder to finally make some money rather than just the bods.
As people here know, I’ve been critical of EVG in the last year due to lack of clarity on milestone payments and lack of new deals for SFX-01. It appears that this lack of clarity actually comes from Stalicla rather than EVG.
However, the share price was around 1.70p recently awaiting news of milestone payments to be received this year of $5.5m.
I believe EVG are due $500k immediately from Stalicla and the remaining $5m in 2024. I don’t believe Stalicla are going to pull the plug on this deal, I think they are simply still analysing the large data which will take a while longer.
I am not sure why they haven’t paid up the $500k but I believe it will be resolved soon and EVG will be paid. I feel the share price has the potential to rise to up to 3p a share if they announce they’ve got the $5.5m this year. That should fund the company into 2026.
I’ve only bought in for £1000 and if I can make enough profit to buy a new iPhone 15 pro I’ll be happy.